Physical Examination for Metabolic Disease: The Overlooked Assessment
The physical examination for metabolic disease extends well beyond BMI and blood pressure. A systematic physical examination can reveal multiple signs of chronic hyperinsulinemia and insulin resistance that are visible, palpable, and clinically actionable. And that provide important context for interpreting laboratory findings. This section describes the physical examination findings most relevant to metabolic assessment, with particular attention to findings that are commonly overlooked or misattributed in standard clinical practice.
Anthropometric Assessment: Beyond BMI
As discussed in the previous section, BMI is an inadequate measure of metabolic risk. The physical examination should include waist circumference and, ideally, waist-to-height ratio as primary measures of visceral adiposity. Waist circumference above 40 inches (102 cm) in men or 35 inches (88 cm) in women meets ATP III criteria for metabolic syndrome and is associated with significantly elevated cardiovascular and metabolic risk. Waist-to-height ratio above 0.5 is a simple, validated predictor of cardiovascular risk that outperforms BMI in most studies.
The distribution of adiposity is clinically informative. Central (visceral) adiposity (the "apple" pattern) is associated with insulin resistance, atherogenic dyslipidemia, and elevated cardiovascular risk. Peripheral (subcutaneous) adiposity (the "pear" pattern) is metabolically less harmful. Visceral fat is metabolically active, secreting adipokines (including TNF-α, IL-6, and resistin) that promote systemic inflammation and insulin resistance, and releasing free fatty acids directly into the portal circulation, driving hepatic insulin resistance and NAFLD.
Acanthosis Nigricans
Acanthosis nigricans. Velvety, hyperpigmented thickening of the skin in body folds and creases, most commonly the posterior neck, axillae, and groin. Is a direct cutaneous manifestation of chronic hyperinsulinemia. Insulin, at supraphysiological concentrations, activates IGF-1 receptors on keratinocytes, driving epidermal proliferation and the characteristic velvety texture. The presence of acanthosis nigricans is a reliable clinical indicator of significant insulin resistance and should prompt fasting insulin measurement regardless of glucose levels.
Acanthosis nigricans is frequently overlooked in clinical practice, particularly in patients with darker skin tones where the hyperpigmentation may be less visually prominent. Careful examination of the posterior neck (asking the patient to flex their neck forward) is the most reliable site for detection. The severity of acanthosis nigricans correlates with the degree of insulin resistance and typically resolves with successful treatment of hyperinsulinemia.
Skin Tags (Acrochordons)
Skin tags (small, soft, pedunculated skin growths) are associated with insulin resistance through the same IGF-1 receptor activation mechanism as acanthosis nigricans. Multiple skin tags in the axillae, neck, or groin are a clinical indicator of chronic hyperinsulinemia and should prompt metabolic assessment. While skin tags are common and not pathognomonic for insulin resistance, their presence in combination with other metabolic signs increases the clinical probability of significant insulin resistance.
Blood Pressure and Pulse Pressure
Hypertension is both a consequence and a driver of metabolic disease. Chronic hyperinsulinemia contributes to hypertension through multiple mechanisms: sodium retention (insulin stimulates renal sodium reabsorption), sympathetic nervous system activation, endothelial dysfunction (via uric acid-mediated inhibition of nitric oxide synthase), and vascular smooth muscle proliferation. A patient with newly diagnosed hypertension and other metabolic markers should be evaluated for insulin resistance as a contributing cause, rather than treated with antihypertensive medications alone.
Pulse pressure (the difference between systolic and diastolic blood pressure) is a marker of arterial stiffness. Elevated pulse pressure (above 40 mmHg) in a patient under 60 years of age suggests premature arterial stiffening, which is associated with advanced glycation end-products (AGEs) (the result of chronic postprandial hyperglycemia) and with the endothelial dysfunction of insulin resistance.
Hepatomegaly and Fatty Liver Signs
Non-alcoholic fatty liver disease (NAFLD) is present in approximately 25% of the global population and is the most common liver disease in the developed world. In advanced cases, hepatomegaly may be detectable on abdominal examination. More commonly, NAFLD is detected incidentally on abdominal ultrasound or suggested by elevated liver enzymes (ALT, AST) on routine laboratory testing.
Elevated ALT (particularly above 30 U/L in women or 40 U/L in men) in the absence of other liver disease is a sensitive marker of hepatic steatosis and should prompt metabolic assessment. The ALT:AST ratio is useful for distinguishing NAFLD (typically ALT > AST) from alcoholic liver disease (typically AST > ALT, ratio > 2:1). Gamma-glutamyl transferase (GGT) is a more sensitive marker of hepatic fat than ALT and is elevated in NAFLD even before ALT rises.
Continuous Glucose Monitoring as a Physical Examination Tool
Continuous glucose monitoring (CGM) (while technically a laboratory tool rather than a physical examination finding) functions as a real-time extension of the physical examination in the metabolic assessment context. A 2-week CGM trial in a patient with suspected insulin resistance provides information that no static laboratory test can capture: the magnitude and duration of postprandial glucose excursions, the glycemic response to specific foods, the relationship between sleep quality and fasting glucose, and the glucose response to exercise.
Prescribing CGM at the initial metabolic assessment visit (before any dietary intervention) serves both a diagnostic and a therapeutic function. Diagnostically, it identifies the specific foods and meal patterns driving the patient's postprandial glucose excursions. Therapeutically, it provides the patient with real-time, personalized feedback on their dietary choices that is far more persuasive than any verbal counseling. Patients who see their own glucose spike to 165 mg/dL after a bowl of oatmeal they believed was healthy are significantly more motivated to make dietary changes than patients who receive only verbal advice.
Integrating the Physical Examination with Laboratory Findings
The physical examination findings described in this section. Acanthosis nigricans, skin tags, central adiposity, elevated pulse pressure, hepatomegaly, elevated liver enzymes. Should be interpreted in the context of the predictive metabolic panel. A patient with acanthosis nigricans, waist circumference of 42 inches, TG:HDL ratio of 4.2, fasting insulin of 18 μIU/mL, and uric acid of 7.1 mg/dL has a consistent, convergent picture of severe insulin resistance that warrants urgent dietary intervention. The physical examination findings provide clinical context that transforms laboratory numbers into a coherent clinical picture.